Shigella flexneri infection: pathogenesis and vaccine development.

Area of Science:

• Microbiology
• Immunology
• Infectious Diseases

Background:

• Shigella flexneri is a gram-negative bacterium responsible for shigellosis, a highly communicable bacterial dysentery causing significant mortality and morbidity globally.
• Shigellosis disproportionately affects children in developing nations, with over 164 million cases and 1.1 million deaths annually.
• The bacterium invades and replicates within the colonic epithelium, leading to inflammation, epithelial destruction, and disease.

Purpose of the Study:

• To review the molecular mechanisms of Shigella flexneri pathogenesis, including invasion, immune evasion, and epithelial cell entry.
• To identify key virulence factors involved in bacterial spread and inflammation induction.
• To explore the host immune response, including humoral and cellular immunity, and its role in protection and disease.

Main Methods:

• Extensive review of in vitro and in vivo studies on Shigella flexneri pathogenesis.
• Analysis of identified virulence factors and their roles in bacterial invasion and spread.
• Examination of host immune responses, including serotype-specific immunity and vaccine development strategies.

Main Results:

• Shigella flexneri utilizes specific molecular mechanisms to invade host cells and spread within the colonic epithelium.
• Inflammation plays a dual role in shigellosis, contributing to epithelial damage and host defense.
• Humoral immunity is important for protection, while the role of cellular immunity requires further clarification.

Conclusions:

• Understanding Shigella flexneri pathogenesis and host immune responses is crucial for developing effective vaccines.
• Despite historical challenges, recent advancements offer promising strategies for S. flexneri vaccine development.
• Current research explores diverse vaccine types, showing progress despite varying efficacy and safety profiles in human trials.